subgroup of
drug)
→
ReceivesAction
→
approved under anda
| Typicality: | 0.250 |
| Saliency: | 0.000 |
| new drug → be approved under → anda | 3 |
| negative | neutral | positive |
| 0.102 | 0.818 | 0.080 |
| Raw frequency | 3 |
| Normalized frequency | 0.000 |
| Modifier score | 0.500 |
| Perplexity | 455.562 |